Shaanxi Key Laboratory of Degradable Medical Material, Northwest University, Xi'an 710069, Shaanxi, China.
Spectrochim Acta A Mol Biomol Spectrosc. 2012 Dec;98:359-66. doi: 10.1016/j.saa.2012.08.048. Epub 2012 Aug 28.
With the compound [Zn(HL(1))(2)(Py)] (H(2)L(1)=2-(1H-benzo[d]imidazol-2-yl)-6-methoxyophenol), Py=pyridine) or [Zn(HL(2))(2)(Py)] (H(2)L(2)=2-(1H-benzo[d]imidazol-2-yl)-4-bromo-6-methoxyphenol) as the precursor, complexes [ZnLn(HL(1))(2)(Py)(NO(3))(3)] (Ln=Nd, 1; Ln=Gd, 2) or [ZnLn(HL(2))(2)(Py)(NO(3))(3)] (Ln=Nd, 3; Ln=Gd, 4) were obtained by the further reaction with Ln(NO(3))(3)·6H(2)O (Ln=Nd or Gd). The result of their photophysical properties shows that the strong and characteristic near-infrared (NIR) luminescence of Nd(3+) ions for complexes 1 and 3 with emissive lifetimes in microsecond range, has been sensitized from the excited state ((1)LC and (3)LC) of the benzimidazole-based ligands, and the involvement of heavy atoms (Br) at the ligand endows the enhanced NIR luminescent property.
以化合物 [Zn(HL(1))(2)(Py)](H(2)L(1)=2-(1H-苯并[d]咪唑-2-基)-6-甲氧基苯酚,Py=吡啶)或 [Zn(HL(2))(2)(Py)](H(2)L(2)=2-(1H-苯并[d]咪唑-2-基)-4-溴-6-甲氧基苯酚)为前体,通过与 Ln(NO(3))(3)·6H(2)O(Ln=Nd 或 Gd)进一步反应,得到配合物 [ZnLn(HL(1))(2)(Py)(NO(3))(3)](Ln=Nd,1;Ln=Gd,2)或 [ZnLn(HL(2))(2)(Py)(NO(3))(3)](Ln=Nd,3;Ln=Gd,4)。它们的光物理性质研究结果表明,来自苯并咪唑配体的激发态((1)LC 和 (3)LC)敏化了 Nd(3+)离子的强特征近红外(NIR)发光,其发射寿命在微秒范围内,并且配体端重原子(Br)的存在赋予了增强的近红外发光性能。